News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Takeda Pharmaceutical Co. Ltd. (TKPYY) COO Dreams Big, Seeks Deals And Global Push In Turnaround Effort


7/3/2014 8:10:29 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Takeda Pharmaceutical Co. (4502) in May reported its lowest profit in 15 years. Japan’s largest drugmaker now must rely on its first foreign chief executive officer to engineer a turnaround.

The 233-year-old Japanese company in April hired former GlaxoSmithKline Plc executive Christophe Weber as chief operating officer and plans to have him succeed CEO Yasuchika Hasegawa next year. Three months on his new job, the 47-year-old Frenchman says he is weighing acquisitions in emerging markets, expansion in faster growth countries and a push to develop internal talent.

Help employers find you! Check out all the jobs and post your resume.

Read at Bloomberg


comments powered by Disqus
Bloomberg
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES